NOSCH LABS PRIVATE LIMITED 100 EOU ON ACCOUNT OF CHEMO SA LUGANO BRANCH

Company Type: Factory (Manufacturer)

Company Introduction:

Nosch Labs Private Limited is an Indian pharmaceutical company primarily engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates. The company operates as a 100 Percent Export Oriented Unit (EOU), signifying its dedication to producing goods for international markets. Nosch Labs maintains a business relationship, likely as a supplier or contract manufacturer, with Chemo SA Lugano Branch, which is part of the global Chemo Group, a prominent entity in the pharmaceutical and chemical industries. Nosch Labs focuses on research, development, and production of high-quality pharmaceutical compounds, adhering to stringent global regulatory standards to meet the demands of its international clientele.

NOSCH LABS PRIVATE LIMITED 100 EOU ON ACCOUNT OF CHEMO SA LUGANO BRANCH manufactures and sells Active Pharmaceutical Ingredients (APIs) and Pharmaceutical Intermediates. Their product portfolio spans several therapeutic categories and includes:

Anti-Retroviral Agents: Lamivudine, Nevirapine, Efavirenz, Zidovudine, Tenofovir Disoproxil Fumarate, Dolutegravir

Anti-Malarial Agents: Artesunate, Lumefantrine, Quinine Sulfate

Anti-Bacterial Agents: Azithromycin, Cefixime, Linezolid, Moxifloxacin Hydrochloride

Anti-Diabetic Agents: Metformin Hydrochloride, Glimepiride, Sitagliptin Phosphate, Empagliflozin

Cardiovascular Agents: Atorvastatin Calcium, Amlodipine Besylate, Valsartan, Clopidogrel Bisulfate

Anti-Viral Agents (Non-HIV): Sofosbuvir, Daclatasvir, Remdesivir, Favipiravir

Central Nervous System Agents: Pregabalin, Gabapentin, Quetiapine Fumarate

Anti-Cancer Agents: Imatinib Mesylate (and related intermediates)

Anti-Fungal Agents: Fluconazole, Itraconazole

Anti-Inflammatory Agents: Ibuprofen, Diclofenac Sodium

Anti-Asthmatic Agents: Montelukast Sodium

Pharmaceutical Intermediates: Various chemical intermediates used in the synthesis of the listed APIs and other complex pharmaceutical compounds.